Results 261 to 270 of about 332,173 (306)
Some of the next articles are maybe not open access.
CBRA: Cardiac biomarkers release analyzer
Computer Methods and Programs in Biomedicine, 2021The most advanced technologies and continuous innovations in the medical field require a necessary interaction between the clinical and the engineering world. In this context, software applications are proposed as a bridge between the two scientific fields and, therefore, as powerful tools, easy to use, and with great analytical skills.
Anna Procopio +9 more
openaire +7 more sources
Advances in Cardiac Biomarkers
Emergency Medicine Clinics of North America, 2005The diagnostic and prognostic roles of new and established cardiac biomarkers are continually changing. This update article discusses clinical diagnosis as a framework for directing biomarker testing. Markers are reviewed in the settings of acute coronary syndromes, decompensated heart failure, and noncardiac clinical scenarios.
Jennifer M, Aviles, Ronnier J, Aviles
openaire +2 more sources
Expert Review of Molecular Diagnostics, 2004
The challenge of medical practice today is to identify individuals who are at risk of developing disease, determine the severity of the disease and distinguish the responders from the nonresponders to therapy (individualized medicine). Advances in molecular genetics and biology have shifted the paradigm for identification of markers from large-scale ...
A J, Marian, Vijay, Nambi
openaire +2 more sources
The challenge of medical practice today is to identify individuals who are at risk of developing disease, determine the severity of the disease and distinguish the responders from the nonresponders to therapy (individualized medicine). Advances in molecular genetics and biology have shifted the paradigm for identification of markers from large-scale ...
A J, Marian, Vijay, Nambi
openaire +2 more sources
Emerging biomarkers for cardiac arrhythmias
Clinical Biochemistry, 2020Cardiac arrhythmias are associated with substantial morbidity and mortality. Recent advances in the pathophysiological understanding of cardiac arrhythmia indicate that inflammation, fibrosis, and even autoimmune mechanisms could facilitate the development of arrhythmias by interfering either with fibroblast activation-related electrical remodeling or ...
Hammerer-Lercher, Angelika +2 more
openaire +3 more sources
2007
Abstract The need for a rapid and reliable diagnosis of myocardial infarction is crucial. Initial efforts focused on clinical assessment and electrocardiography, but over time it became clear that they are often nondiagnostic. Therefore, clinicians now rely heavily on cardiac biomarkers.
Brian P. Shapiro +2 more
openaire +1 more source
Abstract The need for a rapid and reliable diagnosis of myocardial infarction is crucial. Initial efforts focused on clinical assessment and electrocardiography, but over time it became clear that they are often nondiagnostic. Therefore, clinicians now rely heavily on cardiac biomarkers.
Brian P. Shapiro +2 more
openaire +1 more source
Cardiac Biomarkers at High Altitude
High Altitude Medicine & Biology, 2014Classically, biomarkers such as the natriuretic peptides (NPs) BNP/NT-proBNP are associated with the diagnosis of heart failure and hs-cTnT with acute coronary syndromes. NPs are also elevated in pulmonary hypertension. High pulmonary artery systolic pressure (PASP) is a key feature of high altitude pulmonary edema (HAPE), which may be difficult to ...
Adrian, Mellor +10 more
openaire +3 more sources
Cardiac biomarkers in heart failure
Clinical Biochemistry, 2014Heart failure is a syndrome characterized by the inability of the heart to meet the body's circulatory demands. Heart failure is a growing health issue worldwide and the prevalence of heart failure is expected to rise as populations age. Therapies and interventions for a variety of cardiac conditions continue to advance and biomarkers will play an ...
Michael E, Liquori +3 more
openaire +2 more sources
Cardiac biomarkers in pulmonary embolism
Thrombosis and Haemostasis, 2008LIPPI, Giuseppe, Favaloro E.J.
openaire +2 more sources
Cardiac biomarkers in Takotsubo cardiomyopathy
International Journal of Cardiology, 2014Takotsubo cardiomyopathy (TTC) has recently been identified [1,2].TTC prevalence is up to 7% of all suspected acute coronary syndromes(ACS) in women, and 1% when both sexes are considered [3,4]. Re-hospitalizations are frequent and TTC mortality rate is higher than inthe general population [5].
Denis, Doyen +7 more
openaire +2 more sources
Perioperative cardiac biomarkers
Current Opinion in Critical Care, 2013We presume that biomarkers will improve identification of patients at risk, leading to interventions and treatments that reduce perioperative adverse events. Risk stratification is multifactorial, and a biomarker must add information to this process, thereby redistributing patients to either higher or lower risk categories, to improve the allocation of
William Scott, Beattie +1 more
openaire +2 more sources